NCT01455181View on ClinicalTrials.gov

A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 19, 2011

Primary Completion Date

April 26, 2012

Study Completion Date

April 26, 2012

Conditions
Hypoparathyroidism
Interventions
DRUG

NPSP558

50, 75, 100 μg

Trial Locations (3)

Unknown

Semmelweis University Medical School, Budapest

University of Pécs, School of Medicine, Pécs

University of Szeged, Szeged

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY